PEJMF (Peijia Medical) EBIT: $-26.9 Mil (TTM As of Dec. 2025)


PEJMF Peijia Medical Ltd PEJMF
76 GF Score
Price $1.39
GF Value $2.75
! 4 Warning Signs
View Full Analysis

What is Peijia Medical EBIT?

Peijia Medical PEJMF 76 EBIT is $-26.9 Mil as of Dec. 2025. GuruFocus rates PEJMF with a GF Score™ of 76/100 and a GF Value™ of $2.75. The stock has 4 warning signs investors should review.

Peijia Medical's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $-18.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $-26.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Peijia Medical's annualized ROC % for the quarter that ended in Dec. 2025 was -12.35%. Peijia Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -35.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Peijia Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -8.12%.

Peijia Medical  (OTCPK:PEJMF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Peijia Medical's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-36.738 * ( 1 - 0% )/( (278.642 + 316.382)/ 2 )
=-36.738/297.512
=-12.35 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=362.222 - 32.85 - ( 83.807 - max(0, 64.511 - 115.241+83.807))
=278.642

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=377.213 - 40.519 - ( 78.127 - max(0, 96.367 - 116.679+78.127))
=316.382

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Peijia Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-36.246/( ( (103.987 + max(-1.416, 0)) + (102.007 + max(-1.967, 0)) )/ 2 )
=-36.246/( ( 103.987 + 102.007 )/ 2 )
=-36.246/102.997
=-35.19 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.175 + 19.077 + 4.182) - (32.85 + 0 + 0)
=-1.416

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.558 + 20.716 + 11.278) - (40.519 + 0 + 1.4210854715202E-14)
=-1.967

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Peijia Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-26.927/331.472
=-8.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peijia Medical EBIT Related Terms

Peijia Medical EBIT Historical Data

* Premium members only.

The historical data trend for Peijia Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peijia Medical EBIT Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -90.13 -56.79 -54.81 -29.79 -27.10

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.21 -9.42 -20.40 -8.80 -18.12

PEJMF vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Peijia Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Peijia Medical EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Peijia Medical's EV-to-EBIT falls into.


PEJMF
76GF Score
Peijia Medical Ltd PEJMF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peijia Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-26.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-26.9 Mil mean?
Peijia Medical (PEJMF) has a EBIT of $-26.9 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Peijia Medical.
Is Peijia Medical's EBIT too high?
Peijia Medical's current EBIT is $-26.9 Mil. Overall, Peijia Medical has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's EBIT compare to ABT and SYK?
Peijia Medical's EBIT of $-26.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Peijia Medical. Peijia Medical's current EBIT is $-26.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current EBIT of $-26.9 Mil. The stock's GF Value™ is $2.75, compared to a current price of $1.39 — trading 49.6% below its estimated fair value. The current EBIT is $-26.9 Mil. Peijia Medical's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current EBIT is $-26.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peijia Medical (PEJMF) Overvalued in 2026?

Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued. The current stock price of $1.39 is trading 49.6% below its estimated GF Value™ of $2.75.

Key valuation signals for PEJMF:

  • EBIT: $-26.9 Mil
  • GF Value™: $2.75 vs. price of $1.39 (49.6% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Peijia Medical Business Description

Other Exchanges 09996:Hong Kong4WO:Germany
Address No.18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
76GF Score

Get the complete analysis for PEJMF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price
$2.75
GF Value